Crescendo-backed Peltram buys ER Plumbing pehub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pehub.com Daily Mail and Mail on Sunday newspapers.
KKR to list majority-owned Australian pub group seeking $271m
Photo: Reuters
May 3, 2021
Private-equity firm KKR is seeking to raise A$352 million ($271.36 million) in the initial public offering of its majority-owned pub group Australia Venue Co. (AVC), according to a memo seen by Reuters.
The raising will be in exchange for a minority stake in one of Australia’s largest pub companies, in a deal valuing the group at A$903 million, according to the document sent to investors on Monday.
Representatives for KKR and Australia Venue declined to comment.
KKR’s current 80% ownership will be significantly diluted as the firm does not intend to sell any shares, a source with knowledge of the deal added, declining to be identified as the person could not speak publicly.
2 Min Read
SYDNEY, May 3 (Reuters) - Private-equity firm KKR is seeking to raise A$352 million ($271.36 million) in the initial public offering of its majority-owned pub group Australia Venue Co. (AVC), according to a memo seen by Reuters.
The raising will be in exchange for a minority stake in one of Australia’s largest pub companies, in a deal valuing the group at A$903 million, according the document sent to investors on Monday.
Representatives for KKR and Australia Venue declined to comment.
KKR’s current 80% ownership will be significantly diluted as the firm does not intend to sell any shares, a source with knowledge of the deal added, declining to be identified as the person could not speak publicly.
Crescent Capital-owned Australian Clinical Labs seeks $315m in IPO
April 21, 2021
Australian Clinical Labs (ACL), a pathology provider owned by domestic private equity firm Crescent Capital Partners, is seeking to raise $315 million in an initial public offering next week, according to a memo seen by Reuters.
The company and its advisors, Merrill Lynch Equities and Goldman Sachs, will offer shares at A$4 each at an institutional bookbuild on April 27, valuing the company at A$809 million, according to the memorandum sent to investors.
A listing of ACL, one of the three big pathology companies in Australia servicing more than 90 private and public hospitals, would be Australia’s largest IPO of the year, adding to the already four-fold increase in public offerings in the first quarter.
Message :
Required fields
SYDNEY, April 21 (Reuters) - Australian Clinical Labs (ACL),
a pathology provider owned by domestic private equity firm
Crescent Capital Partners, is seeking to raise $315 million in
an initial public offering next week, according to a memo seen
by Reuters.
The company and its advisors, Merrill Lynch Equities and
Goldman Sachs, will offer shares at A$4 each at an institutional
bookbuild on April 27, valuing the company at A$809 million,
according to the memorandum sent to investors.
A listing of ACL, one of the three big pathology companies
in Australia servicing more than 90 private and public
hospitals, would be Australia s largest IPO of the year, adding